Kiniksa Pharmaceuticals International, plc

Insider sale · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
insider.sell
Occurred
2026-07-29
Reported
2026-07-31
Disclosure lag
2 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityKiniksa Pharmaceuticals International, plc
SourceSEC EDGAR ↗
News sectioncompanies
Source identifier0001337798-26-000004
Source-linked related entitiescole-g-bradley-1337798 · person
Event ID#201440

Related recorded events

same canonical or source-linked entity relations
ReportedTypeEventSource
2026-07-31GiftEvent #201441SEC EDGAR
2026-07-28New filingEvent #109235SEC EDGAR
2026-07-28New filingEvent #108843SEC EDGAR

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0001337798-26-000004",
  "acquired_disposed": "D",
  "code": "S",
  "direct_or_indirect": "D",
  "form": "4",
  "is_derivative": false,
  "issuer_name": "Kiniksa Pharmaceuticals International, plc",
  "label": "Open market sale",
  "person_name": "Cole G Bradley",
  "price": 81.43,
  "role": "Director",
  "security": "Class A Ordinary Share",
  "shares": 3673,
  "shares_owned_after": 11672,
  "source_path": "edgar/data/1337798/0001337798-26-000004.txt",
  "ticker": "KNSA",
  "value": 299092.39
}

Evidence-based analysis

facts, provenance and explicit model coverage
Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.
DimensionStatus / valueMethod or boundary
What happenednot_coveredThe source record has no short title or summary.
Whensource_backed · reported 2026-07-31Occurred 2026-07-29. Source-record timestamps; no timezone or event time is inferred.
Affected entitiesresolved · Kiniksa Pharmaceuticals International, plc · 1 relatedCanonical primary entity and stored related_entity_ids only.
Event classificationinsider · insider.sellcanonical event type plus source-provided category; no sentiment or impact is inferred
Entity linkingresolvedCanonical entity resolved during ingestion
Deduplicationappliedunique source event key at ingestion
Source trusthigh · terms allowedSource registry metadata
Sentimentnot_coveredNo sentiment model output is published for this record.
Market reactionnot_coveredRequires licensed quote, candle and volume observations for the affected instrument.
Historical analogsnot_coveredRequires an audited event-cluster corpus and matching methodology.
Impact mechanismnot_coveredNo causal market-impact model is published for this record.
Related risksnot_coveredRisk implications require an audited instrument/entity exposure model.
Instrument linkagenot_coveredNo instrument relation is inferred from an entity event; licensed instrument mapping is required.

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-07-31T00:00:00Z

Kiniksa Pharmaceuticals International, plc — recorded event — investment.com